Th17 cells promote ferroptosis by secreting cytokines that disrupt antioxidant defenses
To view or add a comment, sign in The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A casecontrol study - ScienceDirect To view or add a comment, sign in First Randomized Trial of Tirzepatide in T1D Shows Benefits Tirzepatide was shown to reduce body weight and insulin doses in adults with type 1 diabetes and obesity, according to a phase 2 trial
It is difficult to consider some confounders (such as dosage, duration of use, comorbidities, and drug combinations) that may influence the occurrence of gastrointestinal toxicity
HUBERMAN: And typically people will take it anywhere from three times per week or five times per week
Notably, mitochondria maintain a distinct pool of GSH that is independent of cytosolic GCL activity
Most people tolerate it well, with minimal side effects